Russia's new nasal vaccine from covid-19

[link to medicalxpress.com (secure)]

When Russian scientists boasted that they had tested a coronavirus vaccine on themselves, reactions ranged from praise of their commitment, to outrage over their methods.

Their actions hint at a difficult reality for Russian policymakers—the country is no longer the vaccine developer it was in Soviet times and it is struggling to match virus research being carried out elsewhere.

Alexander Gintsburg of Moscow's Gamaleya research institute said last week he had taken a dose of a so-called viral vector vaccine that he hopes will complete clinical trials by the end of the summer.

He wants then to start producing his vaccine, which is similar to one being developed by Chinese firm CanSino.

Russia is among the countries racing to develop a vaccine and the Gamaleya project is one of several homegrown initiatives.

But Gamaleya's self-experiments were condemned by the country's clinical research association as a "crude violation of the foundations of clinical research conduct, Russian legislation, and international norms."

Last Edited by TSPNS on 05/30/2020 10:40 PM